The phase 2 trials noted dose-dependent increases in heart rate that peaked around 24 weeks and declined thereafter, suggesting the body adapts over time
To qualify for Wegovy treatment, adults should have a body mass index (BMI) of at least 30 kg/ m or a BMI of at least 27 kg/m with at least one weight-related condition, such as hypertension (high blood pressure), diabetes, or dyslipidemia (high cholesterol)
Without insurance, tirzepatide can cost approximately $1,000 monthly, and coverage changes or prior authorization denials may force patients to stop treatment abruptly
Glucagon is generally known as a hormone that raises blood sugar, but it plays a different role in retatrutides design
The significant reduction in total Tau levels observed in the STZ group reflects compromised microtubule stability and extensive neuronal loss rather than pathological Tau hyperphosphorylation[41]
*Correspondence: Juan Huang, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers